Our New Q/A Forum Is Here!   Click Here To Start Exploring Now.

Pre Hospital Hub Logo

Digoxin Effect

27 Dec 2023

Tags: ECGs

Digoxin Effect Introduction

Digoxin is a medication commonly used to treat various heart conditions, primarily heart failure and certain irregular heart rhythms like atrial fibrillation. It belongs to a class of drugs called cardiac glycosides.

Digoxin effects refers to several findings on an ECG and indicates that the patient is taking digoxin – the following ECG findings is not an indicator of digoxin toxicity.  

Digoxin Effect On The Heart

Increased Contractility

Digoxin strengthens the force of heart muscle contractions. It does this by inhibiting the sodium-potassium pump in heart cells, leading to an increase in calcium levels within the cells. This elevated calcium helps the heart muscle contract more forcefully, improving the heart’s pumping action.

Slowing of Heart Rate

Digoxin can also slow down the heart rate, particularly in cases of atrial fibrillation. By affecting the electrical conduction in the heart, it can help regulate and control the heartbeat.

Reduction of Symptoms

By improving the heart’s pumping ability, digoxin helps reduce symptoms of heart failure, such as shortness of breath and fatigue.

     Watch Digoxin Effect on ECGs…

    Digoxin Effect – ECG Findings

    Digoxin therapeutic dosages are usually associated with:

    A distinctive downward-sloping ST segment

    A short QT interval (< 350 ms)

    Abnormal T waves (flattened, inverted, or biphasic)

      Digoxin Effect ECG

      ST Changes

      Digoxin can cause a scooped appearance of the ST segment, mimicking ST segment depression. This effect is sometimes referred to as “reverse tick” or “scooped” or “Salvador Dali’s moustache” ST depression.

        Digoxin Effect - ST

        T Wave

        A biphasic T wave with an initial negative deflection and a terminal positive deflection is the most prevalent type of T-wave abnormality.

        The depressed ST segment usually coincides with the first portion of the T wave. The terminal positive deflection could have a prominent U wave superimposed on it, or it could be peaked.

          T Wave Changes Digoxin Effect e1703636100596 Digoxin Effect

          Other ECG Changes

          Increase PR interval may be present due to the effect of digoxin slowing down the conduction of electrical impulses through the atrioventricular (AV) node.

          Prominent U Waves

          J Point Depression

          Slow Heart Rate

            ECG Examples

            [dnxte_image_magnifier magnifier_upload=”https://prehospitalhub.co.uk/wp-content/uploads/2024/01/ECG-Digoxin-Effect.jpg” image_alt=”magnifier” magnifier_lens_width=”200px” _builder_version=”4.23.1″ _module_preset=”default” custom_padding=”7px|||||” global_colors_info=”{}”][/dnxte_image_magnifier]

            Looking at rate & rhythm, it can be seen that it is irregularly irregular with lack of distinguishable P waves.

            There is distinctive downward scooped ST segment most evident in Leads I, aVL and V4-V6.

            Some T waves are also abnormal in Leads II and Lead III.

            The findings from this ECG suggests AF and Digoxin Effect

            [dnxte_image_magnifier magnifier_upload=”https://prehospitalhub.co.uk/wp-content/uploads/2024/01/ECG-Posterior-AMI-2.jpg” image_alt=”magnifier” magnifier_lens_width=”200px” _builder_version=”4.23.1″ _module_preset=”default” global_colors_info=”{}”][/dnxte_image_magnifier]

            Rate & rhythm is regular with P waves present. 

            ST depression can be seen in the anterior septal region (V1-V4) – this ST depression does not resemble classic digoxin downward scooping ST segment.

            There are dominant R-Waves in lead V2-V3, with Q Waves also seen in aVL and Lead I.

            The findings from this ECG suggests Posterior STEMI. To confirm this leads V4-V6 can be moved around to the back to V7-V9 position which would show ST elevation.

            Conclusion

            Digoxin can cause characteristic ECG changes such as PR interval prolongation, bradycardia, ST segment alterations, T-wave abnormalities, and various arrhythmias.

              Key Points

              • Digoxin may cause changes in the ST segment, appearing scooped or mimicking ST segment depression.

              • It can result in T-wave alterations, such as flattening, inversion, or a biphasic appearance.

              • Despite its use to treat arrhythmias, digoxin can paradoxically cause them, resulting in various conduction disturbances observed on an ECG.

              Bibliography

              Djohan, A. H., Sia, C. H., Singh, D., Lin, W., Kong, W. K., & Poh, K. K. (2020). A myriad of electrocardiographic findings associated with digoxin use. Singapore medical journal61(1), 9–14. https://doi.org/10.11622/smedj.2020005

              Joint Royal Colleges Ambulance Liaison Committee and Association of Ambulance Chief Executives (2022). JRCALC Clinical Guidelines 2022. Class Professional Publishing

              Digoxin Effect Introduction

              Digoxin is a medication commonly used to treat various heart conditions, primarily heart failure and certain irregular heart rhythms like atrial fibrillation. It belongs to a class of drugs called cardiac glycosides.

              Digoxin effects refers to several findings on an ECG and indicates that the patient is taking digoxin – the following ECG findings is not an indicator of digoxin toxicity.  

              Digoxin Effect On The Heart 

              Increased Contractility

              Digoxin strengthens the force of heart muscle contractions. It does this by inhibiting the sodium-potassium pump in heart cells, leading to an increase in calcium levels within the cells. This elevated calcium helps the heart muscle contract more forcefully, improving the heart’s pumping action.

              Slowing of Heart Rate

              Digoxin can also slow down the heart rate, particularly in cases of atrial fibrillation. By affecting the electrical conduction in the heart, it can help regulate and control the heartbeat.

              Reduction of Symptoms

              By improving the heart’s pumping ability, digoxin helps reduce symptoms of heart failure, such as shortness of breath and fatigue.

              Digoxin Effect – ECG Findings

              Digoxin therapeutic dosages are usually associated with:

              A distinctive downward-sloping ST segment

              A short QT interval (< 350 ms)

              Abnormal T waves (flattened, inverted, or biphasic)

              Digoxin Effect ECG

              ST Changes

              Digoxin can cause a scooped appearance of the ST segment, mimicking ST segment depression. This effect is sometimes referred to as “reverse tick” or “scooped” or “Salvador Dali’s moustache” ST depression.

              Digoxin Effect - ST

              T Wave

              A biphasic T wave with an initial negative deflection and a terminal positive deflection is the most prevalent type of T-wave abnormality.

              The depressed ST segment usually coincides with the first portion of the T wave. The terminal positive deflection could have a prominent U wave superimposed on it, or it could be peaked.

              T Wave Changes Digoxin Effect e1703636100596 Digoxin Effect

              Other ECG Changes

              Increase PR interval may be present due to the effect of digoxin slowing down the conduction of electrical impulses through the atrioventricular (AV) node.

              Prominent U Waves

              J Point Depression

              Slow Heart Rate

              ECG Examples

              [dnxte_image_magnifier magnifier_upload=”https://prehospitalhub.co.uk/wp-content/uploads/2024/01/ECG-Digoxin-Effect.jpg” image_alt=”magnifier” magnifier_lens_width=”200px” _builder_version=”4.23.1″ _module_preset=”default” global_colors_info=”{}”][/dnxte_image_magnifier]

              Looking at rate & rhythm, it can be seen that it is irregularly irregular with lack of distinguishable P waves.

              There is distinctive downward scooped ST segment most evident in Leads I, aVL and V4-V6.

              Some T waves are also abnormal in Leads II and Lead III.

              The findings from this ECG suggests AF and Digoxin Effect

              [dnxte_image_magnifier magnifier_upload=”https://prehospitalhub.co.uk/wp-content/uploads/2024/01/ECG-Posterior-AMI-2.jpg” image_alt=”magnifier” magnifier_lens_width=”200px” _builder_version=”4.23.1″ _module_preset=”default” custom_margin=”-32px||1px|||” global_colors_info=”{}”][/dnxte_image_magnifier]

              Rate & rhythm is regular with P waves present. 

              ST depression can be seen in the anterior septal region (V1-V4) – this ST depression does not resemble classic digoxin downward scooping ST segment.

              There are dominant R-Waves in lead V2-V3, with Q Waves also seen in aVL and Lead I.

              The findings from this ECG suggests Posterior STEMI. To confirm this leads V4-V6 can be moved around to the back to V7-V9 position which would show ST elevation.

              Conclusion

              Digoxin can cause characteristic ECG changes such as PR interval prolongation, bradycardia, ST segment alterations, T-wave abnormalities, and various arrhythmias.

              Key Points

              • Digoxin may cause changes in the ST segment, appearing scooped or mimicking ST segment depression.

              • It can result in T-wave alterations, such as flattening, inversion, or a biphasic appearance.

              • Despite its use to treat arrhythmias, digoxin can paradoxically cause them, resulting in various conduction disturbances observed on an ECG.

              Watch Digoxin Effect On ECGs

              Bibliography

              Djohan, A. H., Sia, C. H., Singh, D., Lin, W., Kong, W. K., & Poh, K. K. (2020). A myriad of electrocardiographic findings associated with digoxin use. Singapore medical journal61(1), 9–14. https://doi.org/10.11622/smedj.2020005

              Joint Royal Colleges Ambulance Liaison Committee and Association of Ambulance Chief Executives (2022). JRCALC Clinical Guidelines 2022. Class Professional Publishing